Background: Mississippi ranks second for childhood obesity prevalence (22%) above the national average of 16 % with significant racial and health disparities. Since March 2020, stay-at home orders, virtual learning, stress, and poor lifestyle may have provided a perfect setup leading to new diagnosis of diabetes and accounting for record high hospitalizations. Objective: To determine the impact of the COVID-pandemic on the rate and clinical characteristics of newly diagnosed pediatric diabetes at University of Mississippi Medical Center.

Methods: Chart review and data comparison completed for patients with new-onset-diabetes between January 20-February 2020 (pre pandemic) ; and between March 2020-October 2020 (pandemic) .

Results: Table 1. African Americans were disproportionately diagnosed with diabetes (64%) . Eighty percent of obese patients had type 2 diabetes with 38% presenting in DKA, 3 patients in HHS. Four patients were COVID-positive on admission.

Conclusions: Our observations corroborate the steep rise in the number of new-onset type 1 and type 2 diabetes, particularly in African Americans, in a highly prevalent obese pediatric population. Additional studies are required to determine the detailed effects of SARS-CoV-2 infection and pandemic associated psychosocial, clinical and biochemical effects on development of diabetes in the pediatric population.


N.Dixit: Research Support; Ascendis Pharma A/S, Boehringer Ingelheim International GmbH, Speaker's Bureau; Ascendis Pharma A/S. S.Pasha: None. A.P.Sukumaran: None. K.Armstrong: None. K.Topaloglu: None. L.Gholson: None. F.Kamran: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at